ImmusanT Alternatives & Competitors
12 companies similar to ImmusanT — Pioneering advancements for celiac disease through innovative diagnostics and th...
Companies similar to ImmusanT
Alvine Pharmaceuticals
Pioneering solutions for autoimmune and gastrointestinal health with a promising treatment...
ARTCLINE GmbH
Innovative therapeutic procedures for Intensive Care Medicine for the treatment of severe...
Immunaeon
Connecting Today's Science to Tomorrow's Cures
Rival Readout
Competing with ImmusanT? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Provenance Biopharmaceuticals
Building a future where the immune system stands strong against cancer and critical diseas...
OncoPep, Inc.
To develop and commercialize targeted immuno-therapeutics which prevent the progression of...
Coley Pharmaceutical Group
Empowering the immune system to conquer illnesses and boost vaccine efficacy.
Nuvig Therapeutics Inc.
Rebalancing Immune Function for Chronic Inflammatory and Autoimmune Diseases
Thymmune Therapeutics
Biotech firm developing thymic cell therapies to restore immune function using machine lea...
Akebia Therapeutics
We're focused on the development & commercialization of therapeutics for people living wit...
Medeor Therapeutics, Inc.
Redefining Transplant
About ImmusanT
ImmusanT is a biotechnology company founded in 2010 in Cambridge, Massachusetts. The company is at the forefront of pioneering advancements for celiac disease through innovative diagnostics and therapeutic solutions. ImmusanT leverages groundbreaking findings in immunology to enhance both diagnosis and treatment method...
Celiac Disease, Immunology, Diagnostics, Therapeutics, Gluten Tolerance, T-cell Test, Peptide-based Therapy, Therapeutic Vaccine, Cambridge, Massachusetts, Medical Research, Immune System, Immunotherapy, Healthcare Innovation
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around ImmusanT: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at ImmusanT on 12 Sep 2024. The 12 companies listed here were last checked between 21 Jun 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.